Budesonide [clinicaltrials_resource:c596ee11408f594ace48ab9c0d713eb3]
intervention [clinicaltrials_vocabulary:intervention]
Budesonide [clinicaltrials_resource:c596ee11408f594ace48ab9c0d713eb3]
Bio2RDF identifier
c596ee11408f594ace48ab9c0d713eb3
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:c596ee11408f594ace48ab9c0d713eb3
arm group [clinicaltrials_vocabulary:arm-group]
intervention desc [clinicaltrials_vocabulary:intervention-desc]
8 mg PL-56 once daily for six months
intervention name [clinicaltrials_vocabulary:intervention-name]
Budesonide
other name [clinicaltrials_vocabulary:other-name]
Nefecon, PL-56 (topical acting, anti-inflammatory agent)
identifier
clinicaltrials_resource:c596ee11408f594ace48ab9c0d713eb3
title
Budesonide
@en
type
label
Budesonide [clinicaltrials_resource:c596ee11408f594ace48ab9c0d713eb3]
@en